Method for selecting a treatment for non-small cell lung cancer using gene expression profiles
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 13, 2014
Grant Date -
Nov 24, 2005
app pub date -
Mar 27, 2003
filing date -
Mar 28, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention identifies and quantifies changes in gene expression associated with non-small cell lung cancer NSCLC by examining gene expression in tissue from normal lung and diseased lung. The present invention also identifies and quantifies expression profiles which serve as useful diagnostic markers as well as markers that are useful to monitor disease states, disease progression, drug toxicity, drug efficacy and drug metabolism.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully